168 related articles for article (PubMed ID: 25220728)
1. Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Lee YS; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
Acta Otolaryngol; 2014 Oct; 134(10):1062-70. PubMed ID: 25220728
[TBL] [Abstract][Full Text] [Related]
2. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
[TBL] [Abstract][Full Text] [Related]
3. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
[TBL] [Abstract][Full Text] [Related]
4. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
[TBL] [Abstract][Full Text] [Related]
6. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
8. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
[TBL] [Abstract][Full Text] [Related]
9. Extracapsular spread in hypopharyngeal squamous cell carcinoma: diagnostic value of FDG PET/CT.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Head Neck; 2013 Dec; 35(12):1771-6. PubMed ID: 23508670
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET prediction of head and neck squamous cell cancer outcomes.
Schwartz DL; Rajendran J; Yueh B; Coltrera MD; Leblanc M; Eary J; Krohn K
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1361-7. PubMed ID: 15611393
[TBL] [Abstract][Full Text] [Related]
13. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM
AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of
Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
[No Abstract] [Full Text] [Related]
16.
Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx.
Meshman J; Wang PC; Chin R; John MS; Abemayor E; Bhuta S; Chen AM
Am J Otolaryngol; 2017; 38(1):31-37. PubMed ID: 27751621
[TBL] [Abstract][Full Text] [Related]
18. Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.
Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim MS
Int J Oral Maxillofac Surg; 2013 Feb; 42(2):158-63. PubMed ID: 23219708
[TBL] [Abstract][Full Text] [Related]
19. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Maruo T; Naganawa S; Hasegawa Y; Nakashima T
Ann Nucl Med; 2013 Apr; 27(3):297-302. PubMed ID: 23337965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
